share this page

Abbott to invest €85 million in the expansion of its Sligo pharmaceutical manufacturing facility

Abbott to invest €85 million in the expansion of its Sligo pharmaceutical manufacturing facility

Published on: Sunday, 12 February 2012

Sligo, 9th February 2012 – Abbott plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo. The investment will result in the creation of up to approximately 175 highly skilled jobs. The expansion of the facility will be completed in 2014. The investment is supported by the Irish Government through IDA Ireland.

The expansion will provide additional space for manufacturing operations to support Abbott’s future pharmaceutical pipeline in the key therapeutic areas of virology, oncology and nephrology and provide additional capacity in Abbott's global pharmaceutical manufacturing network. The new jobs that will be created will be highly skilled and include roles in engineering, quality, pharmaceutical science and other science-based areas. The majority of the jobs will be added during the construction phase and the remainder will come on stream post the completion of the expansion. In addition, construction employment will create up to 150 temporary jobs.

Read the Abbott press release here.